Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 5.966B
March 31, 2026 6.074B
December 31, 2025 6.230B
September 30, 2025 6.106B
June 30, 2025 6.491B
March 31, 2025 6.228B
December 31, 2024 6.158B
September 30, 2024 7.287B
June 30, 2024 7.258B
March 31, 2024 7.427B
December 31, 2023 7.720B
September 30, 2023 7.699B
June 30, 2023 8.052B
March 31, 2023 8.401B
December 31, 2022 8.609B
September 30, 2022 8.522B
June 30, 2022 8.961B
March 31, 2022 9.478B
Date Value
December 31, 2021 9.700B
September 30, 2021 8.094B
June 30, 2021 8.264B
March 31, 2021 6.933B
December 31, 2020 7.232B
September 30, 2020 7.386B
June 30, 2020 7.326B
March 31, 2020 7.346B
December 31, 2019 7.311B
September 30, 2019 7.408B
June 30, 2019 7.607B
March 31, 2019 9.221B
December 31, 2018 9.104B
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 9.477B

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 1.623B
Champions Oncology, Inc. 22.92M
Personalis, Inc. 76.97M
Adaptive Biotechnologies Corp. 490.02M
10X Genomics, Inc. 204.52M

Total Liabilities (Quarterly) Related Metrics